rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Daiichi Sankyo

Rediff.com  »  News  »   Daiichi Sankyo

  News for Daiichi Sankyo

  • News
  • Business

Abe, Singh to meet today; investment deals likely

The annual summit between India and Japan on Saturday will seek to forge greater bilateral trade and investment ties, with Japanese Prime Minister Shinzo Abe coming with a high-powered business......

The post-modernist politics of Kerala

M K Bhadrakumar, who is in Kerala covering the election, offers his take on how the importance of politics is receding for the average Malayali. Among the perennial passions of the people of......

Is Dilip Shanghvi's big bet worth the risk?

Ranbaxy's frequent run-ins with the US FDA may have proved too much for its previous owner, Japan's Daiichi Sankyo, but for Sun Pharma, it is an astute purchase that it hopes will not only boost......

Singh brothers count on disclosure to counter Daiichi claims

Facing arbitration claims by Daiichi Sankyo, Ranbaxy's former Indian promoters - Malvinder Mohan Singh, his brother Shivinder Mohan Singh and family - are counting on certain clauses in the share......

Daiichi drags Malvinder to Singapore court

Daiichi Sankyo has claimed damages arising from its settlement with the US authorities, says a source.Daiichi Sankyo, the Japanese parent of Ranbaxy Laboratories, has dragged the latter’s......

Singapore could be possible site for Ranbaxy arbitration

If Daiichi Sankyo, Japanese parent of Ranbaxy Laboratories, decides to pursue arbitration against the latter’s previous promoters, this might be in Singapore, it is learnt.According to......

Daiichi was given all updates: Malvinder Singh

A day after Daiichi Sankyo, the Japanese owner of troubled drug maker Ranbaxy, alleged certain former shareholders had concealed and misrepresented critical information concerning the US Department......

  People speak for daiichi sankyo

  • QNA
Q. Ranbaxy to delist---news. How far will it be beneficial to the Indian shareholders? Your views?
:  A. it would be of benefit to the shareholders of the company but the value addition expected over the long term will be missed out due to this as it...... more

http://qna.rediff.com/questions-and-answers/ranbaxy-to-delist---news.-how-far-will-it-be-beneficial-to-t//answers/16835060

Good Citizen
Q. Japanese company who has purchased Ranbaxy offering higher price of ranbaxy share from the open market. Could we hold the shares or sale to Japanese company ?
Good Citizen:  A. Daiichi Sankyo Co. is the Japanese company that recently purchased Ranbaxy labs. more

http://qna.rediff.com/questions-and-answers/japanese-company-who-has-purchased-ranbaxy-offering-higher-p/16830692/answers/10926389

DrKumarChatterjea
Q. tax Implications of Ranbaxy and Daiichi Sankyo deal.
DrKumarChatterjea :  A. none,,, it will b on stock exchange more

http://qna.rediff.com/questions-and-answers/tax-implications-of-ranbaxy-and-daiichi-sankyo-deal./10926270/answers/9516022

  Web results for Daiichi Sankyo
Drive Multichannel Innovation and Internal Collaboration

PRWeb 2014-04-24 Speakers from Pfizer, Merck, Daiichi Sankyo, Janssen, Hale Advisors, and Johnson & Johnson will lead informative sessions to... ...

http://www.bizwireexpress.com/showstoryPRWeb.php?storyid=199981
BEARING RANBAXY BURDEN

The takeover of Daiichi Sankyo owned Ranbaxy Labs by Sun Pharmaceuticals for $4 billion including a $800 million liability early this month... ...

http://www.pharmabiz.com/ArticleDetails.aspx?aid=81520&sid=3
Japanese Sales Practices at Pharmaceutical Firms

/PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/76c5mf/japanese_sales) has announced the addition of the"... ...

http://in.advfn.com/p.php?pid=nmona&article=61919855
Dermatological Drugs Market Forecast 2014-2024

/PRNewswire/ -- Future Prospects for Leading Companies Dermatological drugs - new study showing you trends, R&D progress, and predicted... ...

http://in.advfn.com/p.php?pid=nmona&article=61914084
Luthra, Amarchand, Crawford, Shearman, Davis Polk advise on Sun Pharma's $4 billion acquisition of

Indian drug maker, Sun Pharmaceutical Industries shall be paying about $4 billion in an all-stock deal to acquire generic drug maker Ranbaxy... ...

http://barandbench.com/content/212/luthra-amarchand-crawford-shearman-davis-polk-advise-sun-pharma%E2%80%99s-4-billion-acquisition

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Related Pages


daiichi sankyo
Daiichi Sankyo

Company
0 Followers

Top Coverage News


Why I love India - Independence Day Special 2013

The Rediff Independence Day Special 2013.

The Programmer Who Came In From The Cold

Whether history will remember Edward Snowden as a traitor to his country or as a champion for...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z